Page last updated: 2024-11-02

oxybutynin and Rhinitis, Allergic

oxybutynin has been researched along with Rhinitis, Allergic in 2 studies

oxybutynin: RN given refers to parent cpd
oxybutynin : A racemate comprising equimolar amounts of (R)-oxybutynin and esoxybutynin. An antispasmodic used for the treatment of overactive bladder.

Rhinitis, Allergic: An inflammation of the NASAL MUCOSA triggered by ALLERGENS.

Research

Studies (2)

TimeframeStudies, this research(%)All Research%
pre-19900 (0.00)18.7374
1990's0 (0.00)18.2507
2000's0 (0.00)29.6817
2010's2 (100.00)24.3611
2020's0 (0.00)2.80

Authors

AuthorsStudies
Tanida, N1
Akiyama, K1
Terahara, T1
Senti, G1
von Moos, S1
Tay, F1
Graf, N1
Johansen, P1
Kündig, TM1

Trials

1 trial available for oxybutynin and Rhinitis, Allergic

ArticleYear
Determinants of efficacy and safety in epicutaneous allergen immunotherapy: summary of three clinical trials.
    Allergy, 2015, Volume: 70, Issue:6

    Topics: Adolescent; Adult; Aged; Conjunctivitis, Allergic; Desensitization, Immunologic; Double-Blind Method

2015

Other Studies

1 other study available for oxybutynin and Rhinitis, Allergic

ArticleYear
[Pharmacological profile and clinical efficacy of transdermal patch containing emedastine difumarate (ALLESAGA
    Nihon yakurigaku zasshi. Folia pharmacologica Japonica, 2018, Volume: 152, Issue:5

    Topics: Animals; Benzimidazoles; Histamine H1 Antagonists; Humans; Rats; Rhinitis, Allergic; Transdermal Pat

2018